ARTICLE | Company News
Gem Pharm, Pharming deal
June 7, 1999 7:00 AM UTC
PHAR will receive exclusive worldwide rights to Gem's lactoferrin as a heparin-neutralizing agent in open heart surgery. PHAR and Gem have an ongoing collaboration to develop the product (see BioCentu...